Gapping up
In reaction to earnings/guidance:
- BILL +15.9% (also confirms acquisition of Divvy for $2.5 bln in cash and stock), GPRO +10.6%, ANGI +9.1%, ROKU +8.5%, CSOD +8.5%, DDOG +7.8% (also names new COO), GRPN +6.5%, NET +6.1%, PBYI +5.9%, EXPE +5.6% (also files for 8.4 mln share offering by selling shareholders), NTRA +5.6%, SVMK +5.5%, PTON +5.4%, FLGT +5.1%, ET +4.9%, ENDP +4.4%, QRTEA +4.4%, RVLV +4.3%, FND +4.2%, AXON +4%, FNKO +3.8%, CARG +3.6%, TSE +3.3%, AVLR +3.2%, MGI +3.2%, BCC +3.1%, GVA +3.1%, UI +3.1%, EOG +2.9%, YELP +2.7%, MCHP +2.7% (also increases dividend), SPB +2.7%, NKTR +2.6%, TWST +2.6%, SQ +2.5%, NWSA +2.5%, TRHC +2.5%, PTMN +2.5%, LXP +2.5%, DBX +2.4%, AMC +2.4%, EB +2.3%, EXEL +2.3%, IAC +2.3%, CABO +2.2%, RPD +2.2%, LYV +2.1%, MCK +2%, MP +1.8%, ZGNX +1.8%, TPIC +1.8%, SCOR +1.7%, IRTC +1.6%, MAIN +1.6%, MTZ +1.5%, CI +1.5%, TU +1.5%, DKNG +1.5%, WFG +1.4%, CNK +1.4%, SYNA +1.3%, RGA +1.2%, HE +1.2%, NFG +1.1%, ZIOP +1%, MSI +1%, CCJ +1%
Other news:
- IBIO +31.9% (reports COVID-19 toxicology study results; announces next-gen COVID-19 vaccine program)
- TTOO +14.7% (announces acceleration of development initiatives under BARDA contract)
- NKTX +13.8% (CRSP and NKTX announce a strategic partnership)
- DDOG +7.7% (names new COO)
- BNTX +7% (Pfizer and BioNTech (BNTX) initiate rolling submission of Biologics License Application for U.S. FDA approval of their COVID-19 vaccine)
- VYNE +5.6% (files for $200 mln mixed securities shelf offering)
- AMSC +2.4% (acquires Neeltran, a supplier of rectifiers and transformers to industrial customers)
- R +2.2% (names new CFO)
- BCS +1.9% (Sherborne Investors Management disclosed it sold 6.01% stake in BCS)
- STWO +1.7% (ESS Inc., a long-duration energy storage solutions company, to become a publicly listed company through merger with ACON S2 Acquisition Corp)
- KSU +1.6% (Surface Transportation Board approves Voting Trust for CP's proposed acquisition of KSU)
Analyst comments:
- VRAY +13% (upgraded to Buy from Neutral at Guggenheim)
- AGS +6% (upgraded to Buy from Hold at Truist)
- TUP +3.1% (upgraded to Buy from Neutral at Citigroup)
- SCS +2.2% (upgraded to Buy from Hold at The Benchmark Company)
- FOUR +1.8% (upgraded to Outperform from Peer Perform at Wolfe Research)
- VIAC +1.2% (upgraded to Equal Weight from Underweight at Wells Fargo; upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- W +1% (upgraded to Hold from Sell at Stifel)